Aarti Drugs

Aarti Drugs Limited is an Indian pharmaceutical company established in 1984 and headquartered in Mumbai. Its core business revolves around the manufacturing and marketing of a diverse range of pharmaceutical products both domestically and internationally. This includes a significant portfolio of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and finished pharmaceutical formulations.

The company's API production encompasses a broad spectrum of therapeutic classes. They manufacture APIs for drugs used in treating pain and inflammation (e.g., diclofenac, nimesulide, aceclofenac), bacterial infections (e.g., ciprofloxacin, levofloxacin, moxifloxacin), fungal infections (e.g., fluconazole, ketoconazole), cardiovascular diseases (e.g., clopidogrel, raloxifene), and diabetes (e.g., metformin, pioglitazone, teneligliptin, vildagliptin). Additionally, they produce APIs for other therapeutic areas such as sleep disorders (zolpidem) and anti-anxiety medications (acamprosate).

Beyond APIs, Aarti Drugs also produces a substantial variety of pharmaceutical intermediates crucial in the synthesis of various drugs. These intermediates are supplied to other pharmaceutical companies for their own drug manufacturing processes. Specific examples include key intermediates for the production of Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem.

Further expanding its chemical capabilities, the company manufactures a range of specialty chemicals, including various benzene and toluene sulfonyl derivatives, as well as other organic chemicals utilized in the pharmaceutical and other chemical industries. This demonstrates a vertically integrated approach, providing Aarti Drugs with control over key raw materials and intermediates.

In summary, Aarti Drugs operates across multiple segments of the pharmaceutical value chain, from the synthesis of basic chemical building blocks to the manufacturing of complex APIs and the development of drugs across several therapeutic areas. Their diversified product portfolio and vertically integrated approach position them strongly within the Indian and international pharmaceutical markets.